Surgalign Holdings Inc
F:RT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Roadside Real Estate PLC
LSE:ROAD
|
UK |
|
Tharisa PLC
OTC:TIHRF
|
CY |
|
Jihua Group Corp Ltd
SSE:601718
|
CN |
|
U
|
USANA Health Sciences Inc
SWB:USJ
|
US |
Surgalign Holdings Inc
Capital Expenditures
Surgalign Holdings Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Surgalign Holdings Inc
F:RT2
|
Capital Expenditures
-$7.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
|
Figs Inc
NYSE:FIGS
|
Capital Expenditures
-$8.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Capital Expenditures
-$97m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-21%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Capital Expenditures
-$102.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-7%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Capital Expenditures
-$36.1m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-11%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Capital Expenditures
-$84.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
What is Surgalign Holdings Inc's Capital Expenditures?
Capital Expenditures
-7.2m
USD
Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Capital Expenditures amounts to -7.2m USD.
What is Surgalign Holdings Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
9%
Over the last year, the Capital Expenditures growth was 44%. The average annual Capital Expenditures growth rates for Surgalign Holdings Inc have been 26% over the past three years , 12% over the past five years , and 9% over the past ten years .